Resilient Biotics, Inc, based in Durham, NC, is a pioneering biotech company focused on developing breakthrough microbiome therapies for respiratory diseases. Their advanced Microbiome Genomics Data Science and Resilient Analytics drive therapeutic discovery, utilizing proprietary databases and analytics pipelines to create innovative microbial products.
Specializing in non-antibiotic, precision microbial therapeutics for both animal and human health, Resilient aims to harness the power of healthy microorganisms as a defense against harmful pathogens. With a commitment to reducing antibiotic dependency, the company is dedicated to providing more effective treatment strategies through cutting-edge microbiome research.
Generated from the website